Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy

Brain Research

Volumn 715, Issue 1-2, 1996, Pages 51-62

  Qian, Jin ^a   Brown, Stephen D ^a   Carlton, Susan M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

allodynia; hyperalgesia; intraperitoneal; N methyl D aspartate (NMDA) receptor antagonist; nociception; non competitive; spontaneous pain

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; COLD STRESS; CONTROLLED STUDY; HYPERALGESIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; PAIN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT;

EID: 0029937786     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01452-7     Document Type: Article

References (67)

1. Aanonsen, L.M., Lei, S. and Wilcox, G.L., Excitatory amino acid receptors and nociceptive neurotransmission in the rat spinal cord, Pain, 41 (1990) 309-321.
2. Aanonsen, L.M. and Wilcox, G.L., Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists, J. Pharmacol. Exp. Ther., 243 (1987) 9-19.
3. Aida, S., Fujiwara, N. and Shimoji, K., Differential regional effects of ketamine on spontaneous and glutamate-induced activities of single CNS neurones in rats, Br. J. Anaesth., 73 (1994) 388-394.
4. Arner, S. and Meyerson, B.A., Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain, Pain, 33 (1988) 11-23.
5. Backonja, M., Arndt, G., Gombar, K.A., Check, B. and Zimmermann, M., Response of chronic neuropathic pain syndromes to ketamine: a preliminary study, Pain, 56 (1994) 51-57.
6. Bennett, G.J. and Xie, Y.-K., A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, Pain, 33 (1988) 87-107.
7. Carlton, S., Gondesen, K., Patterson, J., Rees, H., Tsuruoka, M. and Willis, W., Behavioral and physiological effects of intrathecal memantine in a primate model of painful peripheral neuropathy, Am. Pain Soc., 13 (1994) A-52.
8. Carlton, S.M. and Hargett, G.L., Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats, Neurosci. Lett., 198 (1995) 115-118.
9. Carlton, S.M., Hargett, G.L. and Coggeshall, R.E., Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin, Neurosci. Lett., 197 (1995) 25-28.
10. Choi, Y., Yoon, Y.W., Na, H.S., Kim, S.H. and Chung, J.M., Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain, Pain, 59 (1994) 369-376.
11. Coderre, T.J., Katz, J., Vaccarino, A.L. and Melzack, R., Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence, Pain, 52 (1993) 259-285.
12. Coderre, T.J. and Melzack, R., The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury, J. Neurosci., 12 (1992) 3665-3670.
13. Coderre, T.J. and Van Empel, I., The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests, Pain, 59 (1993) 345-352.
14. Coderre, T.J. and Van Empel, I., The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and noncompetitive NMDA antagonists with agents acting at allostericglycine and polyamine receptor sites, Pain, 59 (1994) 353-359.
15. Cohen, M.L., Chan, S.L., Way, W.L. and Trevor, A.J., Distribution in the brain and metabolism of ketamine in the rat after intravenous administration, Anesthesiology, 39 (1973) 370-376.
16. Conti, F., Minelli, A., Molnar, M. and Brecha, N.C., Cellular localization and laminar distribution of NMDAR1 mRNA in the rat cerebral cortex, J. Comp. Neurol., 343 (1994) 554-565.
17. Davar, G., Hama, A., Deykin, A., Vos, B. and Maciewicz, R., MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy, Brain Res., 553 (1991) 327-330.
18. Delander, G.E. and Wahl, J.J., In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception, Eur. J. Pharmacol., 159 (1989) 149-156.
19. Dickenson, A.H. and Sullivan, A.F., Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat, Brain Res., 506 (1990) 31-39.
20. Eide, P.K., Jorum, E., Stubhaug, A., Bremnes, J. and Breivik, H., Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo, Pain, 58 (1994) 347-354.
21. Eide, P.K., Stubhaug, A., Oye, I. and Breivik, H., Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia, Pain, 61 (1995) 221-228.
22. Farrant, M., Feldmeyer, D., Takahashi, T. and Cull-Candy, S.G., NMDA-receptor channel diversity in the developing cerebellum, Nature, 368 (1994) 335-339.
23. Furuyama, T., Kiyama, H., Sato, K., Park, H.T., Maeno, H., Takagi, H. and Tohyama, M., Region-specific expression of subunits of ionotropic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in the rat spinal cord with special reference to nociception, Mol. Brain Res., 18 (1993) 141-151.
24. Garrison, C.J., Dougherty, P.M. and Carlton, S.M., Quantitative analysis of substance P and calcitonin gene-related peptide immunohistochemical staining in the dorsal horn of neuropathic MK-801-treated rats, Brain Res., 607 (1993) 205-214.
25. Haley, J., Sullivan, A.F. and Dickenson, A.H., Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat, Brain Res., 518 (1990) 218-226.
26. Huntley, G.W., Vickers, J.C., Janssen, W., Brose, N., Heinemann, S.F. and Morrison, J.H., Distribution and synaptic localization of immunocytochemically identified NMDA receptor subunit proteins in sensory-motor and visual cortices of monkey and human, J. Neurosci., 14 (1994) 3603-3619.
27. Jacobson, W. and Cottrell, G.A., Rapid visualization of NMDA receptors in the brain: characterization of (+)-3-[125I]-iodo-MK-801 binding to thin sections of rat brain, J. Neurosci. Methods, 46 (1993) 17-25.
28. Jensen, T.S. and Yaksh, T.L., The antinociceptive activity of excitatory amino acids in the rat brainstem: an anatomical and pharmacological analysis. Brain Res., 569 (1992) 255-267.
29. Kim, S.H. and Chung, J.M., An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat, Pain, 50 (1992) 355-363.
30. Klepstad, P., Maurset, A., Moberg, E.R. and Oye, I., Evidence of a role for NMDA receptors in pain perception, Eur. J. Pharmacol., 187 (1990) 513-518.
31. Kristensen, J.D., Post, C., Gordh, T., Jr. and Svensson, B.A., Spinal cord morphology and antinociception after chronic intrathecal administration of excitatory amino acid antagonists in the rat, Pain, 54 (1993) 309-316.
32. Lee, H. and Choi, B.H., Density and distribution of excitatory amino acid receptors in the developing human fetal brain: a quantitative autoradiographic study, Exp. Neurol., 118 (1992) 284-290.
33. Leem, J.W., Willis, W.D. and Chung, J.M., Cutaneous sensory receptors in the rat foot, J. Neurophysiol., 69 (1993) 1684-1699.
34. Leem, J.W., Willis, W.D., Weller, S.C. and Chung, J.M., Differential activation and classification of cutaneous afferent in the rat, J. Neurophysiol., 70 (1993) 2411-2424.
35. Lodge, D. and Johnson, K.M., Noncompetitive excitatory amino acid receptor antagonist, Trends Pharmacol. Sci., 11 (1990) 81-86.
36. Mao, J., Price, D.D., Hayes, R.L., Lu, J., Mayer, D.J. and Frenk, H., Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy, Brain Res., 605 (1993) 164-168.
37. Mao, J., Price, D.D., Mayer, D.J. and Hayes, R.L., Pain-related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury, Brain Res., 588 (1992) 144-149.
38. Mao, J., Price, D.D., Mayer, D.J., Lu, J. and Hayes, R.L., Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy, Brain Res., 576 (1992) 254-262.
39. Mathisen, L.C., Skjelbred, P., Skoglund, L.A. and Oye, I., Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain, Pain, 61 (1995) 215-220.
40. Maurset, A., Skoglund, L.A., Hustveit, O. and Oye, I., Comparison of ketamine and pethidine in experimental and postoperative pain, Pain, 36 (1989) 37-41.
41. Meldrum, B. and Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends Pharmacol. Sci., Special Report (1991) 54-62.
42. Mjellem-Joly, N., Lund, A., Berge, O.-G. and Hole, K., Potentiation of a behavioural response in mice by spinal coadministration of substance P and excitatory amino acids, Neurosci. Lett., 133 (1991) 121-124.
43. Näsström, J., Karlsson, U. and Berge, O., Systemic or intracerebroventricular injection of NMDA receptor antagonists attenuates the antinociception activity of intrathecally administered NMDA receptor antagonists, Brain Res., 623 (1993) 47-55.
44. Näsström, J., Karlsson, U. and Post, C., Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice, Eur. J. Pharmacol., 212 (1992) 21-29.
45. Okuda, T., Comparison of direct and indirect depressant actions of ketamine on dorsal horn cells in rabbits, Neuropharmacology, 25 (1986) 433-440.
46. Oye, I., Paulsen, O. and Maurset, A., Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors, J. Pharmacol. Exp. Ther., 260 (1992) 1209-1213.
47. Persson, J., Axelsson, G., Hallin, R.G. and Gustafsson, L.L., Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization, Pain, 60 (1995) 217-222.
48. Petralia, R.S., Yokotani, N. and Wenthold, R.J., Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody, J. Neurosci., 14 (1994) 667-696.
49. Peyton, S.H., Couch, A.T. and Bost, R.O., Tissue distribution of ketamine: two case reports, J. Anal. Toxicol., 12 (1988) 268-269.
50. Ren, K., Hylden, J.L.K., Williams, G.M., Ruda, M.A. and Dubner, R., The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation, Pain, 50 (1992) 331-344.
51. Seltzer, Z., Cohn, S., Ginzburg, R. and Beilin, B., Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge, Pain, 45 (1991) 69-75.
52. Shaw, P.J., Ince, P.G., Johnson, M., Perry, E.K. and Candy, J., The quantitative autoradiographic distribution of [3H]MK-801 binding sites in the normal human spinal cord, Brain Res., 539 (1991) 164-168.
53. Sosnowski, M., Pain management: physiopathology, future research and endpoints, Sup. Care Cancer, 1 (1993) 79-88.
54. Stannard, C.F. and Porter, G.E., Ketamine hydrochloride in the treatment of phantom limb pain, Pain, 54 (1993) 227-230.
55. Steel, J.H., Terenghi, G., Chung, J.M., Na, S.H., Carlton, S.M. and Polak, J.M., Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model, Neurosci. Lett., 169 (1994) 81-84.
56. Sugimoto, T., Bennett, G.J. and Kajander, K.C., Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine, Pain, 42 (1990) 205-213.
57. Tacconi, S., Ratti, E., Marien, M.R., Gaviraghi, G. and Bowery, N.G., Inhibition of [3H]-(+)-MK 801 binding to rat brain sections by CPP and 7-chlorokynurenic acid: an autoradiographic analysis. Br. J. Pharmacol., 108 (1993) 577-582.
58. Tal, M. and Bennett, G.J., Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat, Neurosci. Lett., 151 (1993) 107-110.
59. Tasker, R.R. and Dostrovsky, J.O., Deafferentation and central pain. In: P.D. Wall and R. Melzack (Eds.), Textbook of Pain, Churchill Livingstone, New York, 1989, pp. 154-180.
60. Thomas, P.K., Clinical features and differential diagnosis of peripheral neuropathy. In: P.J. Dyck, P.K. Thomas, E.H. Lambert and R. Bunge (Eds.), Peripheral Neuropathy, Saunders, Philadelphia, PA, 1984, pp. 1169-1190.
61. Watanabe, M., Inoue, Y., Sakimura, K. and Mishina, M., Distinct distributions of five N-methyl-D-aspartate receptor channel subunit mRNAs in the forebrain, J. Comp. Neurol., 338 (1993) 377-390.
62. Watanabe, M., Mishina, M. and Inoue, Y., Distinct spatiotemporal expressions of five NMDA receptor channel subunit mRNAs in the cerebellum. J. Comp. Neurol., 343 (1994) 513-519.
63. Watanabe, M., Mishina, M. and Inoue, Y., Distinct distributions of five NMDA receptor channel subunit mRNAs in the brainstem, J. Comp. Neurol., 343 (1994) 520-531.
64. Watanabe, M., Mishina, M. and Inoue, Y., Distinct gene expression of the N-methyl-D-aspartate receptor channel subunit in peripheral neurons of the mouse sensory ganglia and adrenal gland, Neurosci. Lett., 165 (1994) 183-186.
65. White, P.F., Marietta, M.P., Pudwill, C.R., Way, W.L. and Trevor, A.J., Effects of halothane anesthesia on the biodisposition of ketamine in rats, J. Pharmacol. Exp. Ther., 196 (1976) 545-555.
66. Woolf, C.J. and Thompson, S.W.N., The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartate acid receptor activation; implications for treatment of post-injury pain hypersensitivity states, Pain, 44 (1991) 293-299.
67. Yamamoto, T. and Yaksh, T.L., Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain, 49 (1992) 121-128.